MLTX - MoonLake Immunotherapeutics Options

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: ARQT MANE ORKA KRYS KYMR NUVL AXSM BMRN RYTM INCY

| Held by: TCAF VHT ESML NUSC ONEQ OPTZ BBC FHLC TMED WSML

Scroll to Statements

Index	-
Market Cap	1.59B
Enterprise Value	1.33B
Income	-257.08M
Sales	0.00M
Book/sh	3.52
Cash/sh	4.33
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	130
IPO	Oct 20, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	5.46
P/C	4.44
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	8.60
Current Ratio	8.60
Debt/Eq	0.40
LT Debt/Eq	0.39
Option/Short	Yes / Yes

EPS (ttm)	-3.87
EPS next Y	-3.63
EPS next Q	-0.92
EPS this Y	-8.24%
EPS next Y	4.93%
EPS next 5Y	6.41%
EPS past 3/5Y	-27.48% -256.78%
Sales past 3/5Y	- -
EPS Y/Y TTM	-68.11%
Sales Y/Y TTM	-
EPS Q/Q	-54.82%
Sales Q/Q	-
Earnings	May 10 AMC
EPS/Sales Surpr.	-9.89% -

Insider Own	13.66%
Insider Trans	-27.40%
Inst Own	82.08%
Inst Trans	13.78%
ROA	-56.40%
ROE	-77.72%
ROIC	-72.64%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-0.51%
SMA50	4.71%
SMA200	15.34%
Trades

Shs Outstand	72.13M
Shs Float	63.60M
Short Float	8.36%
Short Ratio	4.92
Short Interest	5.32M
52W High	62.75 -69.38%
52W Low	5.95 222.94%
Volatility	4.29% 5.62%
ATR (14)	1.00
RSI (14)	51.27
Beta	1.05
Rel Volume	0.75
Avg Volume	1.08M
Volume	113,230

Perf Week	-1.31%
Perf Month	7.35%
Perf Quarter	12.50%
Perf Half Y	71.72%
Perf YTD	45.79%
Perf Year	-58.90%
Perf 3Y	-62.20%
Perf 5Y	87.83%
Perf 10Y	-
Recom	1.75
Target Price	31.00
Prev Close	19.15
Price	19.22
Change	0.34%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)